
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-05 | Kalra Balkrishan | Director & President and CEO | Sale | 2,800 | $40.77 | $114K | 525.0K | View ↗ |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net revenues | $5.08B+6.6% | $4.77B+6.5% | $4.48B+2.4% | $4.37B+8.7% | $4.02B |
| Cost of revenue | $3.25B+5.6% | $3.08B+5.9% | $2.91B+2.5% | $2.83B+9.4% | $2.59B |
| Gross profit | $1.83B+8.3% | $1.69B+7.6% | $1.57B+2.2% | $1.54B+7.3% | $1.43B |
| Selling, general and administrative expenses | $1.05B+8.2% | $967.1M+5.9% | $913.1M-2.7% | $938.4M+8.4% | $865.7M |
| Amortization of acquired intangible assets | $24.3M-8.2% | $26.5M-15.9% | $31.5M-26.3% | $42.7M-27.0% | $58.4M |
| Other operating (income) expense, net | $9.8M+274.5% | -$5.6M-19.1% | -$4.7M-108.9% | $53.2M+4521.9% | -$1.2M |
| Income from operations | $750.2M+6.9% | $702.1M+11.3% | $630.9M+25.6% | $502.2M-1.3% | $509.0M |
| Foreign exchange gains, net | $7.4M+151.6% | $2.9M-31.3% | $4.3M-72.2% | $15.4M+21.5% | $12.7M |
| Interest income (expense), net | -$49.6M-5.0% | -$47.2M+1.5% | -$47.9M+8.2% | -$52.2M-1.5% | -$51.4M |
| Other income (expense), net | $22.1M+16.3% | $19.0M+26.7% | $15.0M+14690.3% | -$103K-100.8% | $12.9M |
| Income before income tax expense | $730.1M+7.9% | $676.8M+12.4% | $602.2M+29.4% | $465.2M-3.7% | $483.1M |
| Income tax expense (benefit) | $177.7M+8.9% | $163.2M+662.0% | -$29.0M-126.0% | $111.8M-1.6% | $113.7M |
| Net income | $552.5M+7.6% | $513.7M-18.6% | $631.3M+78.6% | $353.4M-4.3% | $369.4M |
| Earnings per common share, basic (in usd per share) | $3K+10.4% | $3K-16.8% | $3K+80.2% | $2K-2.5% | $2K |
| Earnings per common share, diluted (in usd per share) | $3K+9.8% | $3K-16.4% | $3K+81.4% | $2K-1.6% | $2K |
| Weighted average number of common shares used in computing basic earnings per common share (in shares) | $173.89B-2.5% | $178.39B-2.2% | $182.35B-1.0% | $184.18B-1.9% | $187.80B |
| Weighted average number of common shares used in computing dilutive earnings per common share (in shares) | $176.65B-2.1% | $180.44B-2.5% | $185.14B-1.6% | $188.09B-2.5% | $192.96B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Genpact Declines 9.4% Since Beating Q1 Earnings & Revenue Estimates
Genpact Limited (G) Caught Up in AI Disintermediation Fears
Why Genpact (G) Stock Is Down Today
G Q1 Deep Dive: Advanced Technology Solutions Drive Growth as Genpact Shifts Toward Agentic Operations